Motilal Oswal has reiterated its BUY rating on Glenmark Pharmaceuticals, setting a compelling price target of Rs 2,430—implying a robust 28% upside from current levels.

Kotak Institutional Equities has issued a resounding BUY call on Crompton Greaves Consumer, setting a fair value target of Rs 410 against the current market price of Rs 344.

Kotak Institutional Equities has issued a BUY recommendation on InterGlobe Aviation (IndiGo), underscoring the carrier’s strategic prowess in capacity planning, international expansion, and differe

Motilal Oswal Financial Services has issued a BUY recommendation on JK Cement, underlining the company’s robust operational execution and ambitious expansion agenda.

Kotak Institutional Equities has issued a BUY Call on Tata Consultancy Services (TCS), maintaining a fair value target of Rs3,800 per share.

Morningstar has issued a BUY recommendation on CRISPR Therapeutics AG (NASDAQ: CRSP), underscoring the stock’s significant undervaluation and robust long-term prospects, in its latest research repo